免费看黄色大片-久久精品毛片-欧美日韩亚洲视频-日韩电影二区-天天射夜夜-色屁屁ts人妖系列二区-欧美色图12p-美女被c出水-日韩的一区二区-美女高潮流白浆视频-日韩精品一区二区久久-全部免费毛片在线播放网站-99精品国产在热久久婷婷-午夜精品理论片-亚洲人成网在线播放

Body-clock study could pave way for new asthma treatment: UK expert

Source: Xinhua| 2018-09-10 20:30:28|Editor: Lu Hui
Video PlayerClose

LONDON, Sept. 10 (Xinhua) -- The human body clock could have a significant impact on the way doctors diagnose and treat asthma, a study by the University of Manchester, home to the largest biological timing research community in Europe, revealed Monday.

The university's Dr Hannah Durrington, who led the study, said their "body clock" work has important implications on clinical practice in asthma and other inflammatory conditions.

A study of over 300 severe asthmatics found their sputum samples were more than twice as likely to have more inflammatory cells, or eosinophils, in morning clinics than in the afternoon. Levels of eosinophils - a biomarker in sputum - are used to guide treatment in severe asthma patients.

Durrington said doctors and patients have long known that asthma symptoms are at their worst in the small hours of the morning. But previous research has shown that the worsening symptoms are biological in cause, rather than a result of lying down.

Durrington said: "These research results are really exciting but at an early stage - our aim was to understand a bit more about how the body clock affects the biochemistry of a person with asthma. Our work should help with the accurate diagnosis and treatment of asthma in the future.

"We feel it may also have important implications on other lung conditions, as well as outside respiratory medicine. Based on our results, different clinical decisions could be made depending on whether the patient is allocated a morning or afternoon appointment. It also points towards opportunities for more personalised treatment for asthma care in the future."

She said in the same way that measuring glucose levels in diabetes allows adjustment of insulin dosing, it could lead in the future see asthmatics monitoring their biomarker chemicals during the day, to help inform optimum treatment times.

The study was funded by Asthma UK, the JP Moulton Charitable Trust, the North West Lung Charity and also the NIHR Manchester Biomedical Research Center. It is published in the latest edition of the American Journal of Respiratory and Critical Care Medicine.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011102351374587991